DEVONIAN HEALTH GROUP INC (GSD.CA) Stock Price & Overview
TSX-V:GSD • CA2518348834
The current stock price of GSD.CA is 12 CAD. Today GSD.CA is up by 0.08%. In the past month the price increased by 4.35%. In the past year, price increased by 7641.94%.
GSD.CA Key Statistics
- Market Cap
- 33.24M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.75
- Dividend Yield
- N/A
GSD.CA Stock Performance
GSD.CA Stock Chart
GSD.CA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to GSD.CA. When comparing the yearly performance of all stocks, GSD.CA is one of the better performing stocks in the market, outperforming 100% of all stocks.
GSD.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GSD.CA. While GSD.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
GSD.CA Earnings
GSD.CA Forecast & Estimates
GSD.CA Groups
Sector & Classification
GSD.CA Financial Highlights
Over the last trailing twelve months GSD.CA reported a non-GAAP Earnings per Share(EPS) of -2.75. The EPS decreased by -298.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.73% | ||
| ROE | -72.55% | ||
| Debt/Equity | 0.01 |
GSD.CA Ownership
GSD.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.16 | 2.553B | ||
| CRON | CRONOS GROUP INC | 38.58 | 1.285B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.108B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.43 | 935.17M | ||
| DHT-U | DRI HEALTHCARE TRUST | 5.1 | 642.517M | ||
| GUD | KNIGHT THERAPEUTICS INC | 127.15 | 602.253M | ||
| WEED | CANOPY GROWTH CORP | N/A | 569.809M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 423.64M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 17.64 | 364.538M | ||
| TSND | TERRASCEND CORP | N/A | 327.378M | ||
| HITI | HIGH TIDE INC | 23.98 | 290.916M | ||
| ACB | AURORA CANNABIS INC | 59.28 | 271.641M | ||
| OGI | ORGANIGRAM GLOBAL INC | 28.6 | 263.504M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find more ETFs on the Canadian exchanges | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About GSD.CA
Company Profile
Devonian Health Group, Inc. is a clinical-stage pharmaceutical company. The company is headquartered in Montmagny, Quebec and currently employs 8 full-time employees. The firm is to develop prescription drugs for the treatment of fibroinflammatory autoimmune diseases including but not limited to atopic dermatitis, radiodermatitis and ulcerative colitis. The company is also involved in the development of cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its Thykamine is an active lead drug candidate with safety and profiles confirmed in several pre-clinical and clinical studies targeting inflammation. Its cosmeceutical products include R-Spinasome and Purgenesis. The Company’s subsidiary, Altius Healthcare LP, focused on selling prescription pharmaceutical products in Canada, under licenses from brand-name pharmaceutical companies.
Company Info
IPO: 2014-09-09
DEVONIAN HEALTH GROUP INC
360 rue des Entrepreneurs
Montmagny QUEBEC G5V 4T1 CA
CEO: Andre P. Boulet
Employees: 10
Phone: 14509792916
DEVONIAN HEALTH GROUP INC / GSD.CA FAQ
What does GSD do?
Devonian Health Group, Inc. is a clinical-stage pharmaceutical company. The company is headquartered in Montmagny, Quebec and currently employs 8 full-time employees. The firm is to develop prescription drugs for the treatment of fibroinflammatory autoimmune diseases including but not limited to atopic dermatitis, radiodermatitis and ulcerative colitis. The company is also involved in the development of cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its Thykamine is an active lead drug candidate with safety and profiles confirmed in several pre-clinical and clinical studies targeting inflammation. Its cosmeceutical products include R-Spinasome and Purgenesis. The Company’s subsidiary, Altius Healthcare LP, focused on selling prescription pharmaceutical products in Canada, under licenses from brand-name pharmaceutical companies.
Can you provide the latest stock price for DEVONIAN HEALTH GROUP INC?
The current stock price of GSD.CA is 12 CAD. The price increased by 0.08% in the last trading session.
What is the dividend status of DEVONIAN HEALTH GROUP INC?
GSD.CA does not pay a dividend.
What is the ChartMill rating of DEVONIAN HEALTH GROUP INC stock?
GSD.CA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of GSD stock?
DEVONIAN HEALTH GROUP INC (GSD.CA) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the ownership details for GSD stock?
You can find the ownership structure of DEVONIAN HEALTH GROUP INC (GSD.CA) on the Ownership tab.